Ian W. McLeod
SVP, Chief Accounting Officer and TreasureratAnika Therapeutics· In the 2025 proxy
Pay in FY2025Anika Therapeutics stock -41.6% the same year
Ian W. McLeod was paid $765.5K in FY2025 (Dec). Anika Therapeutics stock fell 41.6% that year.
Pay$100 in the stock at the end of FY24 → $58
Experience
- Anika TherapeuticsPublic company · 1 yr
- SVP, Chief Accounting Officer and Treasurer2025 – Present · 1 yrStock in role +32%
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?